During early embryonic development, migrating neural crest cells expressing the 13 NOTCH ligand Delta1 (DLL1) trigger the activation of NOTCH1 signaling in selected 14 epithelial cells within newly formed somites. A key event in this process is a dramatic 15 inhibition of GSK3β activity, initiated by the activation of NOTCH1 and that takes place 16 independent of its transcriptional function. Here, we investigated the mechanism whereby 17 NOTCH1 exerts its non-canonical function in somites. Using the activation of 18 myogenesis as a read-out of the ability of NOTCH receptors to trigger transcription-19 independent responses in somites, we found that all NOTCH receptors (1-4) activate 20
INTRODUCTION 34
During early embryogenesis, extensive tissue rearrangements and cell migration, 35 associated with rapid cell fate changes, allow the formation of the tissues and organs of 36 the future adult. A model where such complex issues are amenable to experimentation is 37 the early formation of skeletal muscles in the chick embryo. Over many days of 38 development, the medial border of the dermomyotome (DML) generates the first skeletal 39 muscle cells that assemble into a primary myotome. This arises from a crucial cell fate 40 decision: epithelial cells in the DML either self-renew or undergo myogenic 41 differentiation, accompanied by an epithelial to mesenchymal transition (EMT) that 42 allows their translocation into the primary myotome [1] [2] [3] [4] . 43 We previously demonstrated that the activation of MYF5 and MYOD in the DML is 44 dependent upon the transient activation of NOTCH signaling, itself triggered by a mosaic 45 expression of Delta1-positive neural crest cells migrating from the dorsal neural tube, a 46 mode of signaling we named "kiss-and-run" mechanism 4 . The molecular response that 47 takes place within DML cells upon activation by neural crest cells was recently 48 characterized 5 . Within DML cells, the "kiss-and-run" mechanism triggers a signaling 49 module encompassing NOTCH, GSK-3β, SNAI1 and β-catenin and which couples the 50 initiation of myogenesis in DML cells with their EMT ( Figure 1A) . 51
In the vast majority of cellular processes, NOTCH utilizes a well-characterized 52
"canonical" pathway initiated by the interaction of NOTCH with cell bound ligands 53 (Delta-like or Jagged). This results in cleavage of NOTCH extracellularly by ADAM 54 proteases, and intracellularly by the γ-secretase complex. This releases NICD, which 55
translocates into the nucleus to interact with RBPJ, converting it into a potent 56 transcriptional activator of downstream target genes 6,7 . One of the remarkable features of 57 the kiss-and-run signaling was that the activation of myogenesis by NOTCH seemed 58 independent of its transcriptional function. This was based on the observation that a 59 membrane-tethered NOTCH Intracellular Domain (NICD) displayed similar activity on 60 myogenesis than NICD, while constitutively active and dominant negative forms of the 61 NOTCH effector RPBJ had no effect on this process ( Figure 1A ). This led to the 62 hypothesis that unconventional functions of NOTCH triggers early myogenesis 5 . Ligand-63
and transcription-independent functions of NOTCH have been reported in a growing 64 number of cellular contexts and are collectively referred to as "non-canonical" NOTCH 65 signaling [8] [9] [10] . NOTCH and WNT/β-catenin signaling are in fact known to interact through 66 non-canonical mechanisms during development and in pathological processes, but in all 67 cases studied, both pathways act antagonistically [11] [12] [13] [14] [15] . In contrast, we found that NOTCH 68
promotes the β-catenin-dependent activation of myogenesis in early somites, suggesting 69 that an atypical interaction is at work between these two major signaling pathways to 70 initiate the myogenic program in developing somites.
71
To decipher the molecular events taking place downstream of NOTCH activation, we 72
have now focused our attention on the mechanism inhibiting GSK-3β function. We 73 demonstrated that in vivo, NICD, GSK3β and AKT work within a complex, in which 74
AKT kinase activity is required to induce MYF5 expression, likely through its inhibitory 75 role on GSK3β. Reinforcing this hypothesis, we found that SNAI1, a direct target of 76
GSK3β, is a necessary step downstream of AKT in the chain of molecular events leading 77
to myogenesis initiation. We present compelling evidence showing that NICD, GSK3β 78
and AKT interact in the cytosol, suggesting a transcription-independent, non-canonical 79 function of NOTCH in this cellular context. We observed that AKT negatively regulates 80 NOTCH transcriptional activity, suggesting that the canonical and non-canonical 81 NOTCH responses are mechanistically linked. Finally, we uncovered that all NOTCH 82
receptors are able to activate MYF5 expression and we show that the RAM domain of 83
NICD is necessary and sufficient in this process. Altogether these data shed a novel light 84 on the molecular mechanisms whereby NOTCH regulates early myogenic differentiation 85
in vertebrates and suggests that such signaling module could be active in a number of 86 cellular contexts. 87 88 RESULTS 89
All four NOTCH receptors are capable of activating MYF5 expression 90
There are four NOTCH receptors in the mouse genome, while only three have been 91 detected in the chicken genome 7,16 . Since all receptors share similar canonical functions 92 (e.g. complex formation with the transcription factor RBPJ), it is plausible that they could 93 also share non-canonical, cytoplasmic activities when placed in similar cellular contexts. 94
We speculated that the electroporation of early somites could serve as an experimental 95 paradigm where this hypothesis could be tested. NOTCH1 was previously identified as 96
the endogenous receptor responsible for triggering MYF5 (and MYOD) expression in the 97 DML of chicken embryos through a transcription-independent mechanism 4 . We therefore 98
used the induction of MYF5 expression as a read-out of the ability of other NOTCH 99 receptors to display similar non-canonical functions. We electroporated the constitutively 100 active forms of all four mouse NOTCH (mNICD1-4) in newly formed somites ( Figure  101 1B). The chicken NICD1 (cNICD1) served as positive control while the electroporation 102
vector alone (H2B-RFP) served as negative control (indicative of MYF5 expression in 103 normal condition). Six hours later, we analyzed those embryos and we compared the 104 expression of MYF5 in the DML of embryos electroporated with these constructs to that 105 of wild type (WT) embryos. We observed that all four NICD induced a robust activation 106 of MYF5 expression (very similar to that of cNICD1, Figures 1C-D), compared to 107 controls. These data indicate that all NICDs share the same ability to activate 108 myogenesis, likely through the signaling module that we previously uncovered, 109
supporting the assumption that all NOTCH receptors are capable of displaying non-110 canonical function in specific cellular contexts.
112
The RAM domain is necessary and sufficient for myogenic activation 113 We then determined which of the domains of NICD is responsible for its non-canonical 114 function. NICD is composed of several domains, including the RAM (RBPJ Associated 115
Module) domain, the 7 Tandem Ankyrin-like Repeats (ANK), the TAD (Trans-Activation 116
Domain) and the PEST domain (Figure 2A 17 ). The RAM domain and ANK repeats are 117 thought to be necessary for NOTCH signaling through the canonical (RBPJ-dependent) 118
pathway 18, 19 . The RAM domain presents high binding affinity for RBP-J and the ANK 119 domain a low binding affinity for this molecule 20,21 . Since both domains are implicated in 120
protein-protein interactions, we wondered whether they could be involved in the 121 molecular events leading to the induction of myogenesis in the cytosol of DML cells. 122
Since the TAD domain is not present in mNICD4 ( Figure 1A ), while this molecule is 123 capable of triggering myogenesis (see above), this excluded a role of TAD in early 124 myogenesis. To test the function of the RAM and ANK domains, deletion constructs for 125 each or both domains were generated and electroporated in DML cells of early chicken 126 embryos ( Figure 2A ). Expression of MYF5 served as a read-out of their activity. As 127
shown in Figures 2B and C, the deletion of the RAM domain significantly decreased the 128 number of MYF5 + electroporated cells as compared to the WT NICD. In contrast, the 129 deletion of the ANK repeats resulted in a percentage of MYF5 + electroporated cells 130 similar to that obtained with the WT NICD. Finally, RAM and ANK deletion presented a 131 significant decrease in MYF5 + cells, similar to that observed in the RAM-only mutant 132
(Figures 2B-C). 133
Since we had previously shown that NICD or a membrane tethered NICD (CD4-NICD) 134
comparably activate MYF5 expression in DML cells 5 , we tested whether the same would 135
apply to the NICD deletion mutants. We have shown previously that the fusion of CD4 to 136 NICD results in a molecule that does not enter the nucleus and is unable to activate 137 NOTCH reporters 5 . We found that the deletion of the RAM domain from the CD4-NICD 138 abrogated the induction of MYF5 expression observed after electroporation of the CD4-139 NICD alone. On the contrary, the deletion of the ANK repeats had no effect (Figure 2 -140 figure supplement 1 A-C). Together these results suggest that the RAM domain of NICD 141
is necessary for activation of myogenesis in the cytosol of DML cells of the chicken 142 embryo. 143
We next determined whether the RAM domain is sufficient to induce MYF5 expression 144 in DML cells. To demonstrate this, we constructed a plasmid that encodes only the RAM 145 domain ( Figure 2A ) and we electroporated it in DML cells. We observed that, compared 146
to non-electroporated control embryos, the RAM domain was sufficient to increase the 147 percentage of MYF5 + cells to a similar level to that observed after electroporation of the 148
Altogether, these results suggest that the RAM domain of NICD is necessary and 150 sufficient to trigger the chain of molecular events leading to the induction of myogenesis 151
in the chicken embryo. Since we have shown previously that RBPJ is not involved in 152 myogenesis in the DML 5 , this suggests that the RAM domain of NICD likely interacts 153
with other protein(s) to mediate its pro-myogenic activity. 154 155 NICD physically interacts with GSK3β and AKT in the cytoplasm of muscle 156
progenitors. 157
Using a reporter for GSK-3β activity, we have previously shown that both NICD and a 158 membrane-tethered CD4-NICD induce a dramatic inhibition of GSK-3β activity 5 . 159
Although previous studies suggested that GSK-3β binds to NOTCH to activate or inhibit 160 its transcriptional activity 22,23 , the mechanism whereby NOTCH could regulate GSK-3β 161 activity is unknown. As a first step towards this aim, we tested whether NICD and GSK-162 3β physically interact in vivo. We performed co-immunoprecipation (co-IP) experiments 163 on total protein extracts of somites electroporated with tagged (myc) NICD and CD4-164 NICD. We analyzed the embryos six hours after electroporation. This focuses on primary 165 events resulting from expression of the constructs. About 40-50 electroporated embryos 166 per condition were tested and the experiments were repeated 3 times. Protein extracts 167
(1mg/lane) showed equivalent amounts of GAPDH protein in all samples ( Figure 3A ). 168
Similar amounts of endogenous GSK-3β protein were also present in all protein extracts 169 and the electroporated constructs (NICD and CD4-NICD) were also detected. Analysis of 170 the immunoprecipitates showed that NICD and CD4-NICD co-precipitated 171
GSK3β ( Figure 3B ). Quantification of three independent co-IPs suggests that NICD 172 physically interacts with GSK3β in muscle progenitors present within the DML ( Figure  173 3C). The observation that the NICD and the membrane-tethered NICD (CD4-NICD) co-174 precipitated GSK-3β, suggests that the physical interaction between NICD and GSK3β is 175 taking place in the cytosol. 176
Since NICD does not display any kinase activity to inhibit GSK-3β, it is unlikely that 177 NICD directly regulates GSK-3β activity. Therefore, it is probable that another kinase(s) 178
is responsible for this effect. A well-documented GSK-3β modulator is the serine 179 threonine kinase AKT (also known as Protein Kinase B) 24-26 , which phosphorylates and 180
inhibits GSK-3β, notably in response to growth factor stimulation or to G-protein-181 coupled receptor (GPCR) activation. 182
We first determined whether AKT is co-expressed with NOTCH when myogenesis is 183 first initiated in developing embryos, i.e. in the medial border of the dermomyotome of 184 newly formed somites (DML) 4 . As in mammals, 3 AKT homologs (1-3) are present in the 185 chicken genome. We performed in situ hybridization with probes for AKT1-3 on 186
developing embryos and we observed that AKT1 is expressed in the DML at the time that 187 muscle progenitors are generated in this structure, supporting the possibility that this 188 molecule could play a role in this process (Figure 3 -figure supplement 1 A-B). This 189 observation is coherent with data in mice, where AKT1 was found to be the main AKT 190 expressed during embryonic development 27 . 191 In the somite extracts electroporated with the two NICD variants described above, we 192
observed that endogenous AKT co-precipitated with NICD and CD4-NICD, suggesting 193 that NICD and AKT proteins physically interact within the cytosol of DML cells (Figures 194 3A-C).
195
Together these results show that NICD directly interacts with GSK3β and AKT at the 196 initial step of the signaling cascade leading to myogenesis. Furthermore, given the 197
reported inhibitory role of AKT on GSK3β, our results suggest that AKT mediates the 198
GSK3β inhibition needed to trigger the signaling cascade for induction of myogenesis in 199 the DML. 200 201
AKT induces MYF5 expression in a kinase-dependent manner. 202
If AKT were to inhibit GSK3β in the DML, modulating its activity should affect 203 myogenesis. To test this we electroporated the DML of developing chicken embryos with 204 a construct coding for a wild type or a constitutively active form of AKT (CA AKT). 205
Quantification of the proportion of electroporated cells expressing MYF5 showed that 206
both WT and CA AKT expression led to a robust increase in the proportion of MYF5-207 positive cells ( Figures 4A-B ). This increase was alike the effect obtained after NICD 208 over-expression in DML cells (see above and 4 ). To verify that the kinase domain is 209
required for this effect we electroporated a kinase-dead form of AKT. In this case, the 210 number of MYF5-positive cells was comparable to control embryos. Altogether, these 211
data suggest that the kinase activity of AKT controls the activation of MYF5 expression 212 in the DML. 213 214
AKT regulates myogenesis through SNAI1 215
The result above is coherent with the hypothesis that AKT acts on GSK3β. However, 216
AKT is a pleiotropic kinase with a multitude of known substrates. Therefore, it is 217 possible that the activation of MYF5 expression we observed after activation of AKT was 218 only partly due to its activity on GSK3β. To address this possibility, we tested whether 219
blocking a downstream target of GSK3β would counteract the AKT-mediated activation 220 of MYF5. A direct consequence of GSK3β inhibition in muscle progenitors is a 221 stabilization of the transcription factor Snail1 (SNAI1) 5 . SNAI1 is a direct target of 222
GSK3β 28 and SNAI1 stabilization is a necessary step for activation of MYF5 in the 223 DML 5 . We have co-electroporated AKT, together with a dominant-negative form of 224 SNAI1 (DN SNAI1 5,29 ). We observed that the increase in MYF5 expression observed 225
with AKT alone was abrogated when DN SNAI1 was co-expressed with AKT ( Figures  226  5A-B ). This confirms SNAI1 activation is a necessary step downstream of AKT-227 mediated MYF5 expression, and altogether reinforces the hypothesis that, within the time 228 frame of these experiments, AKT regulates GSK3β activity in the DML. 229 230 AKT, independent of its kinase activity, negatively regulates NOTCH 231 transcriptional function 232
The data above strongly suggest that AKT is a novel component of the signaling module, 233
upstream of SNAI1, which translates the activation of NOTCH by migrating DLL1-234 positive neural crest cells into an initiation of the myogenic program in DML cells. To 235 test whether AKT may also regulate the canonical function of NOTCH, we co-236 electroporated increasing amounts of a tagged form of AKT together with a NOTCH 237 reporter 4 . We observed that the activity of the reporter decreased with the increasing 238 quantity of AKT ( Figures 6A-B) . The decrease in NOTCH transcriptional activity is 239 likely independent of AKT kinase activity, since the co-electroporation of a dominant-240 negative (DN, i.e. kinase-dead) and a constitutively active mutant forms of AKT led to a 241 similar decrease in the NOTCH reporter activity ( Figures 6C-D) . Finally, we found that 242 the NOTCH transcriptional activity was similarly decreased when membrane-tethered 243
forms of AKT and DN AKT were electroporated in DML cells ( Figures 6E-F) . 244
Altogether, these data suggest that the balance between the transcriptional and non-245
transcriptional activities of NOTCH is mechanistically linked in DML cells. The 246 mechanism whereby this regulation may take place is yet to be uncovered, but our data 247
suggest that it may be due to an interaction between NICD and AKT that takes place in 248 the cytosol.
The purpose of this study was to characterize the mechanism whereby NOTCH plays 252 non-canonical (ligand-dependent, but transcription-independent) functions in the DML.
253
The demonstration that NOTCH, AKT and GSK3β physically interact in the cytosol of 254
DML cells provides direct evidence for a role of NICD in the cytoplasm of those cells 255 (Figure 7) . It also identifies the binding of GSK3β to NOTCH as the initiating event, 256
immediately downstream of NOTCH activation by incoming neural crest cells, in the 257 signaling module leading to the initiation of MYF5 expression in this tissue. 258
The identification of AKT in a protein complex with NOTCH suggests a possible 259 mechanism whereby NOTCH could inhibit GSK3β activity: GSK3β being a major target 260 of AKT 24-26 , it is tempting to postulate that its activity is inhibited by AKT within a 261 protein complex encompassing all three molecules. AKT is a pleiotropic kinase that acts 262 on a number or targets in various cellular contexts. In muscles, AKT is a major regulator 263 of muscle mass through the mTOR and FoxO anabolic and catabolic pathways 30 . 264
However, the observation that SNAI1 activation is a necessary step downstream of 265
GSK3β and AKT supports a model whereby, within the short time frame of our 266 experiments in DML cells, AKT regulates myogenesis solely through its action on 267
GSK3β (Figure 7) . 268
Interestingly, it was shown that the phosphorylation of NOTCH by GSK3β positively 269
regulates canonical (transcriptional) NOTCH signaling in vitro 23 . It is thus possible that 270 this explains the decrease in NOTCH transcriptional activity we observed with increasing 271
AKT concentration ( Figure 6 ). AKT and GSK3β would then act as molecular switches 272
between canonical and non-canonical NOTCH signaling.
273
AKT is itself activated by the stimulation of receptor tyrosine kinases (RTK) or G-274 protein-coupled receptors (GPCR). Binding to their cognate ligand leads to plasma 275 membrane recruitment and activation of the phosphoinositide 3-kinase (PI3K) that in turn 276 activates AKT 31 . The uncovering that AKT plays a role in the signaling module 277
triggering myogenesis therefore suggests that additional inputs from RTKs and/or GPCRs 278
into the pathway leading to the activation of the myogenic program may play a role 279 during this process. The nature of this signal(s) is only speculative at this point. Many 280
FGFs (which signal through FGFR1-4 RTKs) are robustly expressed by the growing 281 myotome, directly adjacent to the DML 29 . Frizzled (GPCR) that transduce WNT signals 282 carried by migrating neural crest cells or secreted by the overlaying ectoderm are also 283 present in the DML 3,5,32,33 . It was also suggested that Sonic Hedgehog (SHH, whose role 284
in early myogenesis has been debated 34 ) activates AKT phosphorylation 35, 36 . Whether in 285 the DML SHH, FGFs, WNTs or other signals synergize with NOTCH signaling via AKT 286
to trigger early myogenic differentiation remains to be shown (Figure 7) . 287
Finally, the observation that the NICDs of all four NOTCH receptors similarly activate 288 myogenesis in the DML strongly suggests that they do so through similar, non-canonical 289 mechanisms. The widespread expression of AKT, GSK3β and the NOTCH receptors 290
suggests that similar interactions between those molecules could take place in many 291 cellular contexts where cell fate changes are associated with an EMT. 292
Since NOTCH is such an extensively studied molecule, it may seem surprising that such 293
interaction of NOTCH with widely expressed kinases was never reported. It is possible 294
that the experimental paradigm we are using (analyses of tissues 2-3 hours after 295 constructs initiate expression) allows detecting events immediately downstream of 296 NOTCH activation that could have gone un-noticed with longer-term approaches. Our 297
finding does not exclude a canonical role for NOTCH. In fact we have shown that in 298 somites, NICD also enters the nucleus where it presumably triggers transcription together 299 with RBPJ 4,5 . However, the phenotypical consequences of its nuclear functions in this 300 tissue are unknown. 301
In conclusion, this study provides novel evidence for a transcription-independent function 302
for NICD in somites and establishes AKT as a novel key player in the signaling cascade 303 that leads to the formation of the early myotome in vertebrates 304 305
MATERIAL AND METHODS 306
Electroporation 307
The somite electroporation technique that was used throughout this study has been 308 described elsewhere 2-4,37 . Briefly, we targeted the expression of various constructs to the 309 dorso-medial portion of newly formed interlimb somites of Hamburger-Hamilton (HH 38 ) 310 stage 15-16 chick embryos (24-28 somites). We have previously shown that this 311 technique allows the specific expression of cDNA constructs in the DML, and that 312 fluorescent reporters (e.g. GFP) are detected 3 hr after electroporation in this structure 39 .
313
We have analyzed all embryos 6 hrs after electroporation, implying that the molecules 314 under study here have been acting during a narrow timeframe (about 3 hrs). 315 316
Expression constructs 317
The following constructs have been previously published: 318
The CAGGS-H2B-RFP (provided by Dr. S. Tajbakhsh 4 ) contains a fusion of Histone 2B 319
with RFP, downstream of the CAGGS strong ubiquitous promoter (CMV/chick β-actin 320 promoter/enhancer). 321
The CAGGS-EGFP 4 contains the CAGGS promoter followed by the EGFP reporter 322 gene. 323
The dominant negative form of SNAI1 consists of the chicken SNAI1, in which the 324 repressor domain was replaced by the VP16 activator domain of the Herpes simplex 325 virus 29 .
326
CAGGS HA-NICD-6xMyc contains the chicken NICD1 (aa 1763-2561) of the chicken 327 NOTCH1, flanked with HA and 6xMyc downstream of the CAGGS promoter 4 . 328
The GSK3 biosensor (pCS2 GFP-GSK3-MAPK, Addgene #29689) contains a CMV 329
promoter upstream of a GFP molecule followed by a polypeptide tail that contains 3 330 GSK-3β phosphorylation sites, a priming site for MAPK/Erk and a site for the binding of 331 E3 polyubiquitin ligases 40 . 332
HES1-d2EGFP (provided by Dr. R. Kageyama) contains the HES1 mouse promoter 333
followed by a destabilized d2EGFP 41 . 334
The membrane tagged NICD was constructed using Gibson assembly (NEB) with the 335 signal peptide FGFR2 (from Danio rerio), the extracellular and transmembrane domain 336 of human CD4 (both obtained from Dr. J Kaslin) followed by the HA tagged NICD 337 previously described, cloned either into the bidirectional vector tetracycline responsive 338 vector or into the pCX-Myc described above.
339
The H2B-BFP has been made by replacing the RFP from the CAGGS-H2B-RFP 340 described above by a TagBFP (Evrogen) 5 .
341
CAGGS-BFP has been made by cloning the TagBFP (Evrogen) into the pCAGGS vector. 342
The following plasmids were constructed: 343
The four mouse NICD have been made by cloning them (addgene 20183, 20184, 20185 344 and 20186) using Gibson simple fragment assembly with pCAAGS HA-NICD-6xMYC 345
(described in 4 ) as a backbone, opened with ClaI and BglII restriction enzymes. 346 347
The deletion mutants of the cNICD1 and the RAM domain have been constructed 348
according to the description domains 42 , by deletion of the pCAAGS HA-NICD described 349
in 5 with a Gibson double fragment assembly with the XbaI enzyme.
351
The delta CD4-NICD have been constructed as the delta NICD, using the pCAAGS CD4 352
HA-NICD-6xMYC 5 as a backbone. The CD4 membrane-tethering tail contains the signal 353 peptide FGFR2 (from Danio rerio), followed by the extracellular and transmembrane 354 domain of human CD4 (both obtained from Dr. J. Kaslin).
356
The AKT variants have been constructed by Gibson simple fragment assembly with 357 pCAAGS HA-NICD-6xMyc described in 4 as a backbone, open with ClaI and EcoRI. The 358
AKT variants were obtained from addgene 39531, 16243 and 17245. 359 360
The CD4-AKT variants have been constructed as the AKT variants, using the pCAAGS 361
CD4 HA-NICD-6xMYC 5 as a backbone. 362 363
Immunohistochemistry, in situ hybridization. 364
Whole-mount antibody staining was performed as described 3 . The following antibodies 365
were used: rabbit polyclonals directed against chick myogenic regulatory factor MYF5 366
(obtained from Dr. B. Paterson 43 ; 1/200); and anti-RFP (Abcam #62341, 1/1000); chicken 367 polyclonal antibody against EGFP (Abcam #13970, 1/1000). Mouse monoclonal 368
antibodies against c-myc-tag (Abcam #32072, 1/200), HA-tag (CST, #2367S, 1/100). In 369 situ hybridization was performed as described 29 . Probes for AKT1, 2 and 3 were isolated 370 by RT-PCR of total RNA extracted from chicken embryonic E19 brain and E14 muscle 371 tissues mixed together. The primers designed for amplification were derived from 372
GenBank chicken AKT1-3 sequences. Amplified fragments (about 600 bp each) were 373
cloned into the pGEM-T vector and sequence-verified. Quantifications and statistical analyses 383
Electroporation results in the transfection of a portion of the targeted cell population, 384
which is variable from embryo to embryo. To precisely evaluate the phenotypes obtained 385
after electroporation of cell-autonomously acting cDNA constructs, the number of 386 positive cells was compared to the total number of electroporated cells, recognized by an 387
internal fluorescent reporter construct. On average, more than 700 cells were counted per 388 point and the corresponding quantifications are shown in all figures. 389
To determine the fluorescence intensity of electroporated cells, the surface of 390 electroporated cells were rendered manually with Imaris software. The mean intensity for 391 each cell and each channel in three-dimensions was collected for statistical analyses. 392
Statistical analyses were performed using the GraphPad Prism software. Mann-Whitney 393 non-parametric two-tail testing was applied to populations to determine the P values 394 indicated in the figures. In each graph, columns correspond to the mean and error bars 395
correspond to the standard deviation. ***p value < 0.001, extremely significant; **p 396 value 0.001 to 0.01, very significant. 397 398
Co-Immunoprecipitation 399
Two and a half day old non-electroporated (WT) chick embryos or embryos 400 electroporated in the DML with HA-NICD-6xcMyc (NICD) or HA-CD4-NICD-6xcMyc 401 (CD4-NICD) were incubated for 6hrs at 37°C. After screening, somites of approximately 402 40 embryos per condition containing electroporated (NICD and CD4-NICD) and non-403 electroporated (WT) DML cells were mechanically dissected under the microscope, 404
homogenized using 26 gauge syringes and lyzed for 1h at 4°C using lysis buffer present 405 in the coIP kit (Active Motif Co-IP kit). Cell Lysates were then centrifuged for 10min at 406
4°C at 14000 rpm and supernatants were dosed using Bio-Rad DC protein assay (DC 407 protein assay kit, Bio-Rad, 500-0116). Cell lysates were subjected to co-IP experiment as Magnetic beads were added to the mix and incubated for 1hr at 4°C. Negative control 411
consists of NICD or CD4-NICD electroporated lysates with only magnetic beads 412 addition. Afterward, beads were collected using a magnetic stick and supernatants were 413 removed. The beads were washed for up to 5 times using the Co-IP/ wash Buffer in the 414
Kit. Lastly, beads were resuspended with 2X Laemmli loading buffer and heated for 415
10min at 95°C before migration on a 10% SDS-page gel and transfer into a PVDF 416 membrane (Millipore, IPVH00010) for western blot analysis. 417 418
Western blot 419
For co-IP inputs lanes, 30 µg of total protein extract samples and co-IP eluates 420
resuspended with 2x Laemmli buffer were separated on a 10% SDS-PAGE gel, then 421 transferred onto PVDF Immobilon-P membranes (Millipore, IPVH00010 Delta1-positive neural crest and epithelial DML cells trigger the activation of NOTCH 520 receptor in the latter. In the cytosol, this leads to the physical binding of NICD, through 521 its RAM domain, to the serine-threonine kinases AKT and GSK3-β. The result of this 522
interaction is a robust inhibition of GSK3-β, which leads to the stabilization of the EMT 523 master gene SNAI1. AKT is an integral part of the signaling module leading to 524 myogenesis, since it's activation triggers MYF5 expression in a SNAI1-dependent 525 fashion. 526 527
